Norway regulator approves Hofseth BioCare listing prospectus
Norway's financial supervisory authority approved Hofseth BioCare's prospectus for listing shares from its private placement. The listing shares will move to the ordinary ISIN and be admitted to trading on Euronext Oslo Børs.
Story updates
12:17:58 PM UTC
SquawkNews
Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the "Company") from 28 June 2026 regarding the successful placing of a private placement of new Ordinary Shares in the Company, each at a fixed price per Ordinary Share of NOK 1.30 (the "Private Placement"). Through the Pr…
12:18:19 PM UTC
SquawkNews
Norway’s FSA approved Hofseth BioCare ASA’s prospectus for its NOK 144.5M private placement; 32,819,999 Listing Shares from Tranche 2 will move to the ordinary ISIN and be admitted to trading on Euronext Oslo Børs.Material DetailsContext by AI AnalystThis finalizes a previously announced capital ra…